Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent
Clinical trial NCT04844749 · TERMINATED
Trial details
- NCT number
- NCT04844749
- Sponsor
- Veru Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-24
- Primary completion
- 2023-05-04
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.